Skip to content
Inciteful Med

Symptoms and Diagnosis: Why 'Normal' Blood Work Isn't the Whole Story

Last updated:

Glanzmann Thrombasthenia is a bleeding disorder where standard blood counts (CBC) appear normal because the patient has enough platelets, but they do not function properly. Diagnosis requires specialized tests like Light Transmission Aggregometry (LTA) to measure platelet function, as basic screenings will miss the problem.

Key Takeaways

  • • Standard CBC tests show normal platelet counts in Glanzmann Thrombasthenia because the defect is functional, not numerical.
  • • Key symptoms include mucocutaneous bleeding like nosebleeds, bleeding gums, and heavy menstrual periods.
  • • Light Transmission Aggregometry (LTA) is the gold standard diagnostic test, showing lack of reaction to ADP and Collagen.
  • • A normal reaction to Ristocetin during testing helps distinguish Glanzmann Thrombasthenia from other disorders.
  • • Genetic testing of ITGA2B and ITGB3 genes can confirm the specific mutation and assist with family planning.

Glanzmann Thrombasthenia (GT) is often called a “hidden” disorder because standard blood tests often come back completely normal. This can be frustrating for patients and parents who know something is wrong. Understanding the specific symptoms and the path to a correct diagnosis is the first step toward effective management.

The Mucocutaneous Bleeding Pattern

GT is characterized by mucocutaneous bleeding, which refers to bleeding from the “wet” surfaces of the body and the skin [1][2]. Because the “hooks” on the platelets are broken, the body struggles to form the initial plug needed to stop bleeding in these delicate areas.

Common symptoms that should trigger a workup include:

  • Epistaxis (Nosebleeds): Frequent, heavy, or long-lasting nosebleeds [1][2].
  • Gingival Bleeding: Bleeding from the gums, especially during brushing or dental work [1][3].
  • Menorrhagia: Extremely heavy or prolonged menstrual periods [1][2].
  • Easy Bruising: Large bruises (purpura or ecchymoses) that appear with little or no known injury [1][4].
  • Petechiae: Tiny, red pinprick spots on the skin caused by minor bleeding under the surface [1].

Why the CBC is “Normal”

When you have a Complete Blood Count (CBC), the lab counts your blood cells. In GT, your body usually produces a healthy, normal number of platelets [1][5]. The CBC “counts the bricks,” but it doesn’t check if the “hooks” (receptors) on those bricks work. Because the count is normal, doctors who aren’t familiar with GT may mistakenly tell you that nothing is wrong [1].

The Diagnostic Path

If GT is suspected, doctors must move beyond basic blood counts to specialized tests that check platelet function.

1. Screening Tests (The Smoke Detectors)

Tests like the PFA-100 (Platelet Function Analyzer) are screening tools. They are like smoke detectors: they can tell you there is a problem, but they can’t tell you exactly what it is [6][7]. In GT, this test will almost always be abnormal (prolonged), indicating that the platelets aren’t doing their job [8][7].
(Note: An older test called “Bleeding Time” involved making a small cut on the arm. This is largely considered obsolete and has been replaced by PFA-100.)

2. Definitive Diagnosis: LTA (The Gold Standard)

Light Transmission Aggregometry (LTA) is the most important test for diagnosing GT [9][10]. In this test, a lab technician adds different “triggers” to your blood to see if the platelets stick together.

  • GT Pattern: Platelets show no reaction to common triggers like ADP, Collagen, or Epinephrine [11][12][1].
  • The Ristocetin Check: Platelets in GT will show a normal reaction to an antibiotic called Ristocetin [13][11][12]. This is crucial because it helps doctors rule out other conditions like von Willebrand Disease or Bernard-Soulier Syndrome [14][11].

3. Flow Cytometry (Counting the Hooks)

Once LTA suggests GT, Flow Cytometry is used to count the actual number of “hooks” (GPIIb/IIIa receptors, also known as CD41 and CD61) on the surface of the platelets [10][15]. This test confirms the diagnosis and identifies the subtype (see Genetics & Subtypes).

4. Genetic Testing

Finally, genetic testing of the ITGA2B and ITGB3 genes can identify the exact mutation causing the disorder [8][11]. This is especially helpful for family planning and identifying other relatives who might be carriers [16][17].

Frequently Asked Questions

Why is my platelet count normal if I have Glanzmann Thrombasthenia?
In Glanzmann Thrombasthenia, the body produces a normal number of platelets ("bricks"), but the receptors ("hooks") on them do not work properly. A standard Complete Blood Count (CBC) only counts the number of cells and does not check if they are functioning, leading to "normal" results despite bleeding symptoms.
What are the common symptoms of Glanzmann Thrombasthenia?
Common symptoms involve "mucocutaneous" bleeding, or bleeding from wet surfaces and skin. This includes frequent nosebleeds, bleeding gums while brushing, extremely heavy menstrual periods, and large bruises that appear without significant injury.
What is the best test to diagnose Glanzmann Thrombasthenia?
Light Transmission Aggregometry (LTA) is considered the gold standard for diagnosis. It tests how platelets react to specific triggers. In GT patients, platelets fail to clump with triggers like ADP or Collagen but show a normal reaction to Ristocetin.
What is the role of flow cytometry in diagnosis?
Flow cytometry is used to count the specific receptors (CD41 and CD61) on the surface of the platelets. This test confirms the diagnosis by showing that these "hooks" are missing or defective and helps determine the specific subtype of the condition.

Questions for Your Doctor

  • • Why was my initial CBC normal despite my frequent bleeding symptoms?
  • • What did my Light Transmission Aggregometry (LTA) results show for ADP and Ristocetin, and how does that confirm GT?
  • • What percentage of GPIIb/IIIa (CD41/CD61) expression did the flow cytometry show?
  • • Does the lab result categorize this as Type I, II, or III Glanzmann Thrombasthenia?
  • • Should we perform genetic testing to confirm the specific mutation in my (or my child's) ITGA2B or ITGB3 genes?

Questions for You

  • • Have I ever had a blood test where the doctor said everything was 'normal' even though I was having bad nosebleeds or bruising?
  • • Which symptoms do I have: nosebleeds (epistaxis), bleeding gums, heavy periods, or easy bruising?
  • • How long do my minor cuts typically bleed before they stop?
  • • Have I had any bleeding after dental procedures or minor surgeries?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Hemorrhage of Upper Digestive and Respiratory Tracts in a Child with Glanzmann Thrombasthenia.

    Michali M, Basiari L, Komnos I, et al.

    Maedica 2023; (18(2)):363-367 doi:10.26574/maedica.2023.18.2.363.

    PMID: 37588843
  2. 2

    Gastrointestinal Bleeding/Angiodysplasia in Patients With Glanzmann Thrombasthenia.

    Tarawah RA, Tarawah AM

    Journal of medical cases 2024; (15(12)):401-405 doi:10.14740/jmc4340.

    PMID: 39610914
  3. 3

    Glanzmann thrombasthenia: a multi-center study of demographics, clinical spectrum, and treatment efficacy.

    Sherief LM, El Ekiaby M, El-Hawy M, et al.

    European journal of pediatrics 2025; (184(5)):318 doi:10.1007/s00431-025-06126-4.

    PMID: 40301132
  4. 4

    Dental Management of Seven-Year-Old Child With Glanzmann Thrombasthenia: A Case Report.

    Alduhayan G, Alsaif A, Almohareb R, Demyati M

    Cureus 2024; (16(9)):e70243 doi:10.7759/cureus.70243.

    PMID: 39463654
  5. 5

    Stem Cell Transplant in Severe Glanzmann Thrombasthenia in an Adult Patient.

    Ramzi M, Dehghani M, Haghighat S, Nejad HH

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016; (14(6)):688-690 doi:10.6002/ect.2014.0165.

    PMID: 26134714
  6. 6

    Platelet abnormalities in patients with Parkinson's disease undergoing preoperative evaluation for deep brain stimulation.

    Chou SC, Tai CH, Tseng SH

    Scientific reports 2022; (12(1)):14625 doi:10.1038/s41598-022-18992-1.

    PMID: 36028530
  7. 7

    Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders.

    Fiore M, Giraudet JS, Alessi MC, et al.

    Orphanet journal of rare diseases 2023; (18(1)):171 doi:10.1186/s13023-023-02787-2.

    PMID: 37386449
  8. 8

    Glanzmann thrombasthenia: genetic basis and clinical correlates.

    Botero JP, Lee K, Branchford BR, et al.

    Haematologica 2020; (105(4)):888-894 doi:10.3324/haematol.2018.214239.

    PMID: 32139434
  9. 9

    Stability and utility of flow cytometric platelet activation tests: A modality to bridge the gap between diagnostic demand and supply.

    Dave RG, Geevar T, Chellaiya GK, et al.

    Platelets 2022; (33(7)):1043-1051 doi:10.1080/09537104.2022.2042232.

    PMID: 35225160
  10. 10

    Flow cytometric analysis of platelet surface glycoproteins in the diagnosis of thirty-two Turkish patients with Glanzmann thrombasthenia: a multicenter experience

    Saraymen B, Muhtaroğlu S, Köker MY, et al.

    Turkish journal of medical sciences 2021; (51(4)):2135-2141 doi:10.3906/sag-2006-107.

    PMID: 33957723
  11. 11

    Glanzmann Thrombasthenia in Pakistani Patients: Identification of 7 Novel Pathogenic Variants in the Fibrinogen Receptor αIIbβ3.

    Siddiqi MYJ, Boeckelmann D, Naz A, et al.

    Cells 2023; (12(2)) doi:10.3390/cells12020213.

    PMID: 36672149
  12. 12

    Identification of one novel pathogenic ITGB3 mutation and two known mutations in two Chinese pedigrees with hereditary Glanzmann thrombasthenia.

    Lu Z, Nikuze L, Zhong Z, et al.

    Platelets 2020; (31(3)):355-359 doi:10.1080/09537104.2019.1615614.

    PMID: 31088191
  13. 13

    Assessment of platelet function on the routine coagulation analyzer Sysmex CS-2000i.

    Frère C, Kobayashi K, Dunois C, et al.

    Platelets 2018; (29(1)):95-97 doi:10.1080/09537104.2017.1353683.

    PMID: 28960123
  14. 14

    Elevated CD9 expression as a potential biomarker for diagnosis of Bernard-Soulier syndrome.

    Sharifi MJ, Vakili E, Ilkhanipoor H, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2022; (33(3)):159-161 doi:10.1097/MBC.0000000000001117.

    PMID: 35165218
  15. 15

    Missed at first Glanz: Glanzmann thrombasthenia initially misdiagnosed as Von Willebrand Disease.

    Doherty D, Singleton E, Byrne M, et al.

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2019; (58(1)):58-60 doi:10.1016/j.transci.2018.11.008.

    PMID: 30551951
  16. 16

    Molecular genetic diagnosis of Tunisian Glanzmann thrombasthenia patients reveals a common nonsense mutation in the ITGA2B gene that seems to be specific for the studied population.

    Aloui C, Chakroun T, Granados V, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018; (29(8)):689-696 doi:10.1097/MBC.0000000000000779.

    PMID: 30325339
  17. 17

    Utility of the ISTH bleeding assessment tool (BAT) in diagnosis of Glanzmann Thrombasthenia patients.

    Saqlain N, Fateen T, Tufail H, Mazher N

    Pakistan journal of medical sciences 2022; (38(4Part-II)):791-795 doi:10.12669/pjms.38.4.5361.

    PMID: 35634602

This guide explains Glanzmann Thrombasthenia diagnosis for educational purposes. Always consult a hematologist for interpretation of your specific blood tests and diagnostic strategy.

Stay up to date

Get notified when new research about Glanzmann Thrombasthenia is published.

No spam. Unsubscribe anytime.